Thanks Candid, if you could point me to other small cap Biotechs that are priced fairly according to your valuation model I would be more inclined to consider it a legitimate methodology.
To be frank, I think your model is incompatible with this end of the market based on my experience and knowledge. Would love to be proven otherwise with some data.
Thanks Candid, if you could point me to other small cap Biotechs...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.196M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 74000 | 1.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.1¢ | 10129 | 1 |
View Market Depth
| Last trade - 07.29am 24/06/2025 (20 minute delay) ? |
| OSX (ASX) Chart |
Day chart unavailable